FDA Extends Regulatory Review Period for Biogen Idec (BIIB)/Elan (ELN) for TYSABRI
Tweet Send to a Friend
Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc. (NYSE: ELN) said the FDA informed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
